Published online Dec 18, 2021. doi: 10.5312/wjo.v12.i12.1036
Peer-review started: March 18, 2021
First decision: July 18, 2021
Revised: August 1, 2021
Accepted: November 28, 2021
Article in press: November 28, 2021
Published online: December 18, 2021
Processing time: 270 Days and 21.9 Hours
Numerous fixation devices have been described in literature for foot and ankle arthrodesis. Each of these devices have their own benefits and drawbacks
This review article looked into the use of an intraosseous device IOFIX. Since the entire construct of IOFIX is embedded in the bone, there is less risk of soft tissue irritation and prominence of metalwork.
Outcome scores, union rates, as well as complications associated with the use of IOFIX was looked into.
Fully published studies with details of the use of intra osseous devices were included in the study. These were identified by a search through available English literature. Nine related publications were identified and analysed.
In comparison to plate/screw constructs there were fewer soft tissue complications and issues of metalwork prominence. It also provided adequate compression across the arthrodesis site.
IOFIX appears to be safe and effective in achieving arthrodesis of the 1st metatarsophalangeal and talonavicular joints with early rehabilitation. However, cadaveric and biomechanical studies on the use in tarsometatarsal and ankle joint showed some concerns with decreased load to failure and cycles to failure.
Further clinical trials are required. Prospective and comparative studies with larger sample size and longer follow-up could confirm the effectiveness and limitations of the method.
